Effects of the Gastrin-Releasing Peptide Antagonist RC-3095 in a Rat Model of Ulcerative Colitis-Reference-Cited by-同舟云学术

Effects of the Gastrin-Releasing Peptide Antagonist RC-3095 in a Rat Model of Ulcerative Colitis

Published:2009-11-06 Issue:8 Volume:55 Page:2203-2210
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Damin Daniel C.,Santos Frederico S.,Heck Renata,Rosito Mário A.,Meurer Luise,Kliemann Lúcia M.,Roesler Rafael,Schwartsmann Gilberto

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-009-1032-9.pdf

Reference36 articles.

1. Podolsky DK. Inflammatory bowel disease. N Eng J Med. 2002;347:417–429.

2. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182–205.

3. Louis E. The immuno-inflammatory reaction in Crohn’s disease and ulcerative colitis: characterization, genetics and clinical application: focus on TNF-alpha. Acta Gastroenterol Belg. 2001;64:1–5.

4. Reinecker HC, Steffen M, Witthoeft T. Enhanced secretion of TNF-alpha, IL-6, and IL-1 by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn’s disease. Clin Exp Immunol. 1993;94:174–181.

5. Sands BE, Kaplan GG. The role of TNF-α in ulcerative colitis. J Clin Pharmacol. 2007;47:930.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrin-releasing peptide receptor antagonist RC-3095 inhibits Porphyromonas gingivalis lipopolysaccharide-accelerated atherosclerosis by suppressing inflammatory responses in endothelial cells and macrophages;Inflammation Research;2024-08-20

2. Discovery of a novel GRPR antagonist for protection against cisplatin-induced acute kidney injury;Bioorganic Chemistry;2022-07

3. Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategies;Nature Reviews Drug Discovery;2021-07-27

4. Insights into bombesin receptors and ligands: Highlighting recent advances;Peptides;2015-10

5. RC-3095, a Selective Gastrin-Releasing Peptide Receptor Antagonist, Does Not Protect the Lungs in an Experimental Model of Lung Ischemia-Reperfusion Injury;BioMed Research International;2015